CARVYKTI 3.2 x 1 000 000 - 1 x 100 000 000 cells, dispersion for infusion bag
Active ingredients: CILTACABTAGÈNE AUTOLEUCEL
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Dispersion for infusionbagintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CARVYKTI 3,2 x 1 000 000 - 1 x 100 000 000 cellules, dispersion pour perfusion
- Pharmaceutical form
- dispersion pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 poche EVA : éthylène vinyl acétate copolymère avec tube d'addition scellé et deux ports de piquage disponibles contenant soit 30mL (poche de 50mL) ou 70mL (poche de 250 mL)
- Marketing authorisation holder
- JANSSEN CILAG INTERNATIONAL NV
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 29 Mar 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
64743778CIP75508911CIP133400955089117Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CILTACABTAGÈNE AUTOLEUCELdispersion | CARVYKTI 3,2 x 1 000 000 - 1,0 x 100 0000 000 cellules · une poche | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.